1. Home
  2. NLSP vs BLNE Comparison

NLSP vs BLNE Comparison

Compare NLSP & BLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BLNE
  • Stock Information
  • Founded
  • NLSP 2015
  • BLNE 2019
  • Country
  • NLSP Switzerland
  • BLNE United States
  • Employees
  • NLSP N/A
  • BLNE N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BLNE
  • Sector
  • NLSP Health Care
  • BLNE
  • Exchange
  • NLSP Nasdaq
  • BLNE NYSE
  • Market Cap
  • NLSP 12.4M
  • BLNE 11.9M
  • IPO Year
  • NLSP 2021
  • BLNE N/A
  • Fundamental
  • Price
  • NLSP $2.68
  • BLNE $1.34
  • Analyst Decision
  • NLSP
  • BLNE
  • Analyst Count
  • NLSP 0
  • BLNE 0
  • Target Price
  • NLSP N/A
  • BLNE N/A
  • AVG Volume (30 Days)
  • NLSP 325.4K
  • BLNE 5.7M
  • Earning Date
  • NLSP 07-07-2025
  • BLNE 08-13-2025
  • Dividend Yield
  • NLSP N/A
  • BLNE N/A
  • EPS Growth
  • NLSP N/A
  • BLNE N/A
  • EPS
  • NLSP N/A
  • BLNE N/A
  • Revenue
  • NLSP N/A
  • BLNE $5,213,000.00
  • Revenue This Year
  • NLSP N/A
  • BLNE $456.73
  • Revenue Next Year
  • NLSP N/A
  • BLNE $28.26
  • P/E Ratio
  • NLSP N/A
  • BLNE N/A
  • Revenue Growth
  • NLSP N/A
  • BLNE 63.03
  • 52 Week Low
  • NLSP $1.30
  • BLNE $0.62
  • 52 Week High
  • NLSP $16.00
  • BLNE $29.80
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 62.59
  • BLNE N/A
  • Support Level
  • NLSP $2.19
  • BLNE N/A
  • Resistance Level
  • NLSP $2.54
  • BLNE N/A
  • Average True Range (ATR)
  • NLSP 0.19
  • BLNE 0.00
  • MACD
  • NLSP -0.01
  • BLNE 0.00
  • Stochastic Oscillator
  • NLSP 57.89
  • BLNE 0.00

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BLNE EASTSIDE DISTILLING INC

Beeline Holdings Inc is a technology-driven mortgage lender and title provider building a fully digital, AI-powered platform that simplifies and accelerates the home financing process.

Share on Social Networks: